Peroxisome Proliferator Activator Receptor γ Coactivator-1 Expression Is Reduced in Obesity
Sarah Crunkhorn(Joslin Diabetes Center), Mary‐Elizabeth Patti(Joslin Diabetes Center), Antônio C. Bianco(University of Bergamo), Farrell Dearie(Joslin Diabetes Center), Kristen Barry(Joslin Diabetes Center), Hiral Gami(Joslin Diabetes Center), Wagner Seixas da‐Silva(Brigham and Women's Hospital), Christos S. Mantzoros(Beth Israel Deaconess Medical Center), Daniel Espinoza(Emory University), Ryan Faucette(Massachusetts General Hospital)
Cited by 235
Related Papers
Role of leptin in the neuroendocrine response to fasting
|Nature|1996|3.1k
Adverse metabolic and cardiovascular consequences of circadian misalignment
|Proceedings of the National Academy of Sciences|2009|2.3k
Obesity and cancer risk: Emerging biological mechanisms and perspectives
|Metabolism|2018|1.6k
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
|Metabolism|2018|1.2k